(Q37920891)

25 August 2017

1 reference

title

Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program (English)

1 reference

idiopathic pulmonary fibrosis

25 August 2017

1 reference

1 reference

1

Luca Richeldi

1 reference

25 August 2017

Roland M du Bois

2

1 reference

25 August 2017

publication date

1 August 2011

1 reference

Expert Review of Respiratory Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

5

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

473-481

1 reference

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

25 August 2017

cites work

1 reference

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

21 January 2018

1 reference

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

21 January 2018

1 reference

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results

21 January 2018

1 reference

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

21 January 2018

1 reference

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Idiopathic pulmonary fibrosis and pirfenidone

21 January 2018

1 reference

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.11.52

1 reference

25 August 2017

1 reference